Cargando…

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis

Non-resolving inflammation is the main mechanism of morbidity and mortality among patients suffering from cystic fibrosis (CF), the most common life-threatening human genetic disease. Resolution of inflammation is an active process timely controlled by endogenous specialized pro-resolving lipid medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Recchiuti, Antonio, Mattoscio, Domenico, Isopi, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454233/ https://www.ncbi.nlm.nih.gov/pubmed/31001110 http://dx.doi.org/10.3389/fphar.2019.00252

Ejemplares similares

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
por: Briottet, Maelle, et al.
Publicado: (2020)

Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
por: Recchiuti, Antonio, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2012)

Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
por: Isopi, Elisa, et al.
Publicado: (2020)

Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders
por: Sousa, Teresa, et al.
Publicado: (2023)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
por: Schebb, Nils Helge, et al.
Publicado: (2022)

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain
por: Leuti, Alessandro, et al.
Publicado: (2021)

Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
por: de Gaetano, Monica, et al.
Publicado: (2018)

Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes
por: Mattoscio, Domenico, et al.
Publicado: (2021)

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
por: Kang, Gyeoung Jin, et al.
Publicado: (2020)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

A Pro-resolving Role for Galectin-1 in Acute Inflammation
por: Law, Hannah L., et al.
Publicado: (2020)

Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
por: Patruno, Sara, et al.
Publicado: (2018)

Distinct Analgesic Actions of DHA and DHA-Derived Specialized Pro-Resolving Mediators on Post-operative Pain After Bone Fracture in Mice
por: Zhang, Linlin, et al.
Publicado: (2018)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
por: Díaz del Campo, Lucía Serrano, et al.
Publicado: (2022)

Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples
por: Kutzner, Laura, et al.
Publicado: (2019)

Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis
por: Di Pietro, Caterina, et al.
Publicado: (2020)

Mitochondrial Stress Responses and “Mito-Inflammation” in Cystic Fibrosis
por: Patergnani, Simone, et al.
Publicado: (2020)

Targeting caveolin-1 deficiency in bone marrow derived cells: a new therapeutic window for fibrotic diseases?
por: Cianci, Eleonora, et al.
Publicado: (2014)

Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
por: Yang, Ailin, et al.
Publicado: (2021)

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators
por: Dahlke, Philipp, et al.
Publicado: (2023)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes
por: Hansen, Trond Vidar, et al.
Publicado: (2019)

Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation
por: Lee, Chun-Teh, et al.
Publicado: (2021)

Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
por: Eickmeier, Olaf, et al.
Publicado: (2017)

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
por: Regidor, Pedro-Antonio, et al.
Publicado: (2020)

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
por: Marangi, Michele, et al.
Publicado: (2018)

Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
por: Basil, Maria C., et al.
Publicado: (2015)

Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation
por: Ferguson, Brittney, et al.
Publicado: (2020)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Specialized pro-resolving lipid mediators in endodontics: a narrative review
por: Aubeux, Davy, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
por: Gila-Diaz, Andrea, et al.
Publicado: (2021)

Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis
por: Rangarajan, Subhapradha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vsbdnb1m4n2j3n0l52fiioog43